Form 4 for TECH Bio-Techne
Accepted 2023-08-08 00:00:00 ET · period of report 2023-08-05 · accession 0001062993-23-016040 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-08 | 2023-08-05 | TECH | Kummeth Charles R. | CEO, Dir | M - OptEx | $0.00 | +51.5K | 1.31M | +4% | $0 |
| D | 2023-08-08 | 2023-08-05 | TECH | Kummeth Charles R. | CEO, Dir | F - Tax | $82.17 | -32.0K | 1.28M | -2% | -$2.63M |
| D | 2023-08-08 | 2023-08-05 | TECH | Kummeth Charles R. | CEO, Dir | M - OptEx | $0.00 | -51.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-05 | M | A | 51,516 | $0.00 | 1,310,282 | D | — | — | (F1) Includes 7,128 shares of restricted stock for which the risk of forfeiture will lapse on August 6, 2024. |
| 2 | Common | Common Stock | 2023-08-05 | F | D | 31,962 | $82.17 | 1,278,320 | D | — | — | (F1) Includes 7,128 shares of restricted stock for which the risk of forfeiture will lapse on August 6, 2024. |
| 3 | Derivative | Restricted Stock Units | 2023-08-05 | M | D | 51,516 | $0.00 | 0 | D | — · — to — | 51,516 Common Stock | (F3) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. (F4) On 8/5/2023, the Board of Directors certified vesting of 51,516 performance RSUs. |